Tag Archives: farnesyltransferase

Tipifarnib Ras Inhibitor Pursued by Kura

A drug that was rejected by the FDA in 2005 for the treatment of acute myeloid leukemia, and has also failed studies in pancreatic cancer will be further developed by a company called Kura, which in-licensed the drug from J&J. Continue reading